Semaglutide
Semaglutide is a novel long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA), with a structure similar to that of natural human glucagon-like peptide-1 (GLP-1), sharing up to 94% amino acid sequence homology. It is used for blood sugar control and weight management in adults with type 2 diabetes.
Product Details:
Semaglutide lowers blood sugar levels by stimulating insulin secretion and reducing glucagon secretion, effectively controlling blood sugar in patients with type 2 diabetes. It can also be used to reduce the risk of heart disease, stroke, and even cancer in overweight/obese adults with cardiovascular conditions. In the field of weight loss, semaglutide also shows excellent results, significantly reducing the risk of major adverse cardiovascular events, including cardiovascular death and non-fatal myocardial infarction.
